Anticoagulation at the extremes of body weight: choices and dosing

Expert Review of Hematology
Georgia J B McCaughanJennifer Curnow

Abstract

The landscape of therapeutic anticoagulation has changed dramatically over the past decade, with availability of direct oral anticoagulants (DOACs), which inhibit factor Xa or thrombin. However, the optimal anticoagulant agent and dosing strategy for patients at both extremes of body weight has not been established for any anticoagulant, including DOACs, vitamin K antagonists (VKA), and the various heparin options. Areas covered: This paper reviews available evidence to assist clinicians in prescribing of anticoagulation therapy at the extremes of body weight. Expert commentary: There are limited data to guide prescribing of all available anticoagulants at the extremes of weight and further research regarding efficacy and safety outcomes in these groups is required. Laboratory monitoring to guide dosing of traditional anticoagulants provides reassurance of 'predictable' efficacy. In contrast agents that are not routinely monitored by laboratory testing provide greater challenges. For example, underweight patients are at risk of receiving higher drug exposures of DOACs, whereas the use of fixed dose DOACs in obese patients may be associated with lower drug exposures.

References

Jun 12, 1979·European Journal of Clinical Pharmacology·P A RoutledgeM D Rawlins
May 1, 1980·Clinical Pharmacokinetics·J W Estes
Jan 7, 1999·International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement·D J MurryD G Poplack
Jun 18, 2002·Pharmacotherapy·Michael D Reed, Dawn Bell
Sep 24, 2002·The Annals of Pharmacotherapy·Randall K AbsherMary H Parker
Oct 18, 2002·Clinical Pharmacokinetics·François DonatRik de Greef
Jun 3, 2004·Annals of Internal Medicine·Harry R BüllerUNKNOWN Matisse Investigators
Apr 27, 2005·Thrombosis Research·Annie BazinetLyne Lalonde
Oct 4, 2005·Clinical Pharmacology and Therapeutics·Dagmar KubitzaGeorg Wensing
Apr 4, 2007·Journal of Thrombosis and Haemostasis : JTH·B L DavidsonUNKNOWN Matisse Investigators
May 29, 2007·Journal of Thrombosis and Thrombolysis·Marcie J Hursting, Ik-Kyung Jang
Oct 24, 2007·Clinical Pharmacology and Therapeutics·P Y HanB Green
Dec 19, 2007·Circulation·Walter AgenoPieter W Kamphuisen
Jan 23, 2008·Journal of Thrombosis and Haemostasis : JTH·R BarbaUNKNOWN Riete Investigators
Jul 1, 2008·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Jeffrey F BarlettaKevin Pendleton
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Dec 8, 2009·The New England Journal of Medicine·Sam SchulmanUNKNOWN RE-COVER Study Group
Jan 14, 2010·Clinical Pharmacokinetics·Michael J HanleyDavid J Greenblatt
Jun 17, 2010·European Journal of Clinical Pharmacology·Kazeem A OshikoyaImti Choonara
Jul 1, 2010·The Annals of Pharmacotherapy·Jennifer N RineyEli N Deal
Dec 7, 2010·The New England Journal of Medicine·Rupert BauersachsSebastian Schellong
Dec 17, 2010·Journal of General Internal Medicine·Adam N HurewitzDonald A Brand
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators

❮ Previous
Next ❯

Citations

Jun 17, 2020·Journal of the American Heart Association·Ashley ChenBruce A Warden
Jan 12, 2021·Journal of Cardiovascular Electrophysiology·Jiří PlášekJosef Kautzner
Dec 29, 2020·Seminars in Thrombosis and Hemostasis·Anders AbildgaardAnne-Mette Hvas
Jul 27, 2021·European Journal of Clinical Investigation·Francesca BodegaUNKNOWN INSigHT (Italian DOACs San Raffaele Hospital) registry investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.